Page 17 - 2 Director Reports (Annexure) 2021.cdr

64-65
and at the same time make a giant leap towards KEY FINANCIAL RATIOS
innovation. New capabilities need to be introduced
Key financial parameters as on 31st March 2021 on the
across the business functions to bring efficiencies and to basis of Standalone Financials for the year ending 31st
help industry move up the value chain. Government also
March 2021 & 31st March 2020 respectively are as
needs to provide the right enablers and business
follows;
environment conducive for growth.
Particulars FY 2021 FY 2020
FIXED ASSETS
Debtors Turnover (days) 50 55
Fixed Assets of the Company are generally well
Inventory Turnover 4.88 4.67
maintained and are in good condition.
Interest Coverage Ratio 53.71 20.05
INTERNAL CONTROL SYSTEMS AND THEIR Current Ratio 2.06 1.77
ADEQUACY Debt Equity Ratio 0.31 0.43
Operating Prot Margin 8.54% 4.92%
Your Company's internal systems are adequate and
Net Prot Margin 8.38% 4.03%
commensurate with the size of operations. These
controls ensure that transactions are authorized, During the year, the return on Net Worth of the
recorded, and reported on time. They ensure that assets Company is 21.18% as compared to the previous
are safe guarded and protected against loss or financial year 10.52%.
unauthorized disposal.
CAUTIONARY STATEMENT
The Internal Audit is carried out in different areas of your
The market data and other information contained herein
company's operations. Post-audit reviews were carried
have been based on the statistics and information
out to ensure that audit recommendations were gathered from various published and unpublished
implemented. Discrepancies and weaknesses, if any,
sources and the company does not take any assurance
found at various levels are timely and suitably addressed
about their authenticity. The company's management
with a view to efficiently manage the company's valuable
reserves the right to revisit any of the analytical
resources.
statements to decide the best course of action for the
HUMAN RESOURCES maximization of Shareholders' value in addition to
meeting social and corporate obligations.
The human capital is an essential ingredient for carrying
out operations of the company. Your company is Certain statements contained in the Management
providing equal opportunity to employees and has Discussions and Analysis Report pertaining to company's
applies fair practices. The company judiciously rewards objectives, strategies, estimates, expectations or
its workforce and values the importance of human predictions, future plans and projections may be forward
capital. The company has strong belief in collective looking statements within the meaning of applicable
efforts of all the team members. Its traditions of fair play, laws and regulations and have been made in good faith.
equal opportunity and value chain enhancement are The actual results may be affected by many factors that
alive and progressing. The inter-personal relationship may be different from what is envisaged in terms of
amongst workers, staff and officers has been pleasant future performance and outlook presented above.
and of peaceful co-existence. As on March 31, 2021,
there were 1510 permanent employees on the rolls of
the company.
For and on behalf of Board of Directors
Sushil Suri
Place: New Delhi (Chairman & Managing Director)
th
Date: 27 July, 2021 DIN: 00012028
ANNEXURE 'H'
BUSINESS RESPONSIBILITY ('BR') REPORT
Pursuant to Regulation 34(2) (f) of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015, as amended.
Being aware and sensitive towards the society and environment, the norms demand responsible behavior as the
world evolves. Across the globe, business ecosystems are getting aligned to deliver sustainable development with
greater social accountability alongwith managing nancial performance, thus making the process a holistic one. As
a responsible business enterprise, Morepen Laboratories Limited (the "company") has always pursued the highest
ethos of corporate responsibility and governance, often beyond the regulatory threshold. Cognizant of its
responsibilities towards the society and the environment, the company has consistently shaped its business
strategies with focus on sustainability.
Pursuant to Regulation 34(2) (f) of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015, as amended, the company is hereunder presenting its Business Responsibility
Report for FY2020-2021:
SECTION A : GENERAL INFORMATION ABOUT THE COMPANY
1 Corporate Identification Number L24231HP1984PLC006028
2 Name of the company Morepen Laboratories Limited
3 Registered address Morepen Village, Nalagarh Road, Malkumraja,
Baddi, Solan, Himachal Pradesh, 173205
4 Website www.morepen.com
5 E-mail i.d. investors@morepen.com
st
st
6 Financial year reported 1 April, 2020 - 31 March, 2021
7 Sector(s) that the company is engaged in (industrial Pharma Sector under Group 210, Class 2100 as
activity code-wise) per the National Industrial Classification 2008
8 List three key products / services that the company Anti-diabetic, Antihistaminic & Antiallergic category
manufactures / provides (as in balance sheet): and Antihyperlipedemic etc.
9 Total number of locations where business activity is
undertaken by the company
i. number of International Locations (Provide details The company has its presence in USA through its
of major 5) wholly owned subsidiary company.
ii. number of national Locations The company is doing its business across India.
There are four manufacturing units of the company,
situated in Himachal Pradesh, India.
10 Markets served by the company Local/ state/ In addition to pan India presence, more than
national/ International seventy international markets are served across
Asia, North America, Brazil, European Union & rest
of the world.
SECTION B: FINANCIAL DETAILS OF THE COMPANY
st
1 Paid up Capital (INR) Rs. 44.98 Crore on 31 March, 2021
2 Total turnover (INR) (Consolidated) Rs. 1200.12 Crore
3 Total profit after taxes (INR) (Consolidated) Rs. 97.08 Crore
4 Total spending on Corporate social responsibility (Cr) Rs. 0.65 Crore
as percentage of profit after tax (%) (Consolidated) More than 2% of the average net profits of the
company made during the immediately three
preceding financial years.
5 List of activities in which expenditure in 4 above a) Healthcare
has been incurred b) Women Empowerment
c) Ensuring environmental sustainability,
ecological balance/ healthcare & sanitation
d) Rural development projects
e) Education